Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-013676
Filing Date
2015-03-03
Accepted
2015-03-03 17:07:17
Documents
1
Period of Report
2015-03-02

Document Format Files

Seq Description Document Type Size
1 form473430_20150303050701-.html 4  
1 form473430_20150303050701-.xml 4 5142
  Complete submission text file 0001144204-15-013676.txt   6513
Mailing Address 745 ROUTE 202-206 SUITE 303 BRIDGEWATER NJ 08807
Business Address 745 ROUTE 202-206 SUITE 303 BRIDGEWATER NJ 08807 908-517-9500
CorMedix Inc. (Issuer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Markvicka Taunia (Reporting) CIK: 0001545282 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34673 | Film No.: 15670134